← Back to Search

Behavioral Intervention

IMARA Program for Sexual Health in Black Girls (IMAGE Trial)

N/A
Waitlist Available
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must not have
AIM 1: Non-English speaking
AIM 2: Inability to understand the consent process, and non-employment at a partnering CBO.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 and 12 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to study how different factors affect the sexual health of Black girls, including sexually transmitted infections (STIs), HIV, and sexual violence. The research will involve Black male caregivers to help protect

Who is the study for?
This trial is for Black male caregivers and their daughters, focusing on preventing STIs, HIV, and sexual violence. Participants must be willing to engage in programs aimed at improving girls' sexual reproductive health outcomes.
What is being tested?
The study tests the IMARA program for Black male caregivers paired with a Girls Empowerment initiative against a control program. It aims to understand how these interventions can influence health outcomes related to STIs/HIV and prevent sexual violence.
What are the potential side effects?
Since this trial involves educational and empowerment programs rather than medical treatments, there are no traditional side effects. However, participants may experience emotional or psychological responses to the content.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.
Select...
I understand the consent process and do not work at a partnering community-based organization.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
STI Incidence in Participants
Secondary study objectives
Number of Participants Using Condoms
Number of Sexual Partners of Participants
Rate of STI History among Participants

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental (IMAGE) GroupExperimental Treatment1 Intervention
The IMAGE group will receive an 8-10-hour HIV/STI group-based (6-8 dyads) prevention program delivered to Black male caregivers and girls over 2-days.
Group II: Control (FUEL) GroupActive Control1 Intervention
The FUEL group will receive a caregiver-adolescent general health promotion program identical in length and intensity to IMAGE.

Find a Location

Who is running the clinical trial?

University of MichiganOTHER
1,853 Previous Clinical Trials
6,432,413 Total Patients Enrolled
University of Illinois at ChicagoLead Sponsor
639 Previous Clinical Trials
1,568,524 Total Patients Enrolled
~408 spots leftby May 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top